Lipid‐based Nano‐delivery systems as a promising strategy for the treatment of epilepsy: Current status and challenges
Epilepsia Open · 2026-08 · 11 (4) · 1095-1110
DOI: 10.1002/epi4.13137 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epilepsia Open, online erschienen am 16.06.2026. Verfasst von Priya Kannan Varshini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sri Shanmugha College of Pharmacy, Sangagiri, India. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Drug Delivery Systems, Lipids. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
Epilepsy is a prevalent chronic neurological disorder characterized by abnormal neuronal electrical activity. The primary treatment modality for individuals with epilepsy (PWE) is antiseizure medication (ASM). The multiple potential factors contributing to treatment resistance in epilepsy may be attributed to the inability of ASMs to traverse the blood–brain barrier (BBB). Consequently, it is imperative to identify a solution, and optimally, enhance ASM efficacy.
Method
Innovative drug delivery technologies have shown improved therapeutic efficacy in the treatment of epilepsy as compared with traditional pharmaceutical treatments. Furthermore, exosomes, neosomes, and phytosomes have received interest as potential next‐generation drug delivery platforms, owing to their benefits over semi‐synthetic and synthetic alternatives. These systems have demonstrated better bioavailability, tailored distribution, and decreased adverse effects, giving them potential choices for boosting the treatment of numerous disorders.
Results
Exploring and optimizing novel drug delivery systems could lead to significant advancements in the treatment of drug‐resistant epilepsy by enhancing the delivery of ASMs to the brain and overcoming barriers like the BBB. Additionally, further research into the mechanisms of action and potential side effects of these innovative drug delivery systems is crucial for their successful clinical translation in epilepsy treatment. Significant Pharmacokinetics and pharmacodynamic can be used to better customize medicines for specific patients, increase efficacy, and lessen side effects. All things considered, the creation of medication delivery systems based on nanotechnology has enormous potential to transform the treatment of epilepsy and enhance patient outcomes. Plain Language Summary Epilepsy is a common neurological illness treated mostly with antiseizure drugs (ASMs), although treatment resistance is typically connected to the difficulty of ASMs to penetrate the blood–brain barrier (BBB). Innovative drug delivery systems, such as exosomes, neosomes, and phytosomes, offer potential advantages over existing approaches by boosting bioavailability, distribution, and minimizing side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sri Shanmugha College of Pharmacy, Sangagiri, India.
ORCID-Profile: Paranthaman Subash, Sulekha Khute
Zitieren
APA
Varshini, P. K., Divya, A., Sowndharya, K., Jeevitha, P., Manoj, S., Rahman, A., Ahamed, A., Abirahul, R., Subash, P., & Khute, S. (2026). Lipid‐based Nano‐delivery systems as a promising strategy for the treatment of epilepsy: Current status and challenges. Epilepsia Open, 11(4), 1095-1110. https://doi.org/10.1002/epi4.13137
Vancouver
Varshini PK, Divya A, Sowndharya K, Jeevitha P, Manoj S, Rahman A, et al. Lipid‐based Nano‐delivery systems as a promising strategy for the treatment of epilepsy: Current status and challenges. Epilepsia Open. 2026;11(4):1095-1110. doi:10.1002/epi4.13137
BibTeX
@article{Varshini2026,
author = {Varshini, Priya Kannan and Divya, Arunachalam and Sowndharya, Kumar and Jeevitha, Parthiban and Manoj, Selvam and Rahman, Ashiq and Ahamed, Athil and Abirahul, Ravichandiran and Subash, Paranthaman and Khute, Sulekha},
title = {Lipid‐based Nano‐delivery systems as a promising strategy for the treatment of epilepsy: Current status and challenges},
journal = {Epilepsia Open},
year = {2026},
volume = {11},
number = {4},
pages = {1095--1110},
doi = {10.1002/epi4.13137}
}
EUVIMED